| Literature DB >> 34179197 |
Tian Zhao1, Jinqi Xiong1, Wen Chen1, Ahui Xu1, Du Zhu1, Jiantao Liu1.
Abstract
BACKGROUND: Cipangopaludina cahayensis contains active fibrinolytic proteins and has been considered a potential anti-cancer agent. However, its anti-cancer characteristics and functions have yet to be elucidated.Entities:
Keywords: Cipangopaludina cahayensis; Fibrinolytic activity; Isolation; Purification; Tumor suppression
Year: 2021 PMID: 34179197 PMCID: PMC8217531 DOI: 10.30498/IJB.2021.2805
Source DB: PubMed Journal: Iran J Biotechnol ISSN: 1728-3043 Impact factor: 1.671
Figure 1Cipangopaludina cahayensis fibrinolytic protease assessments. A total of 8 labeled halos are shown representing the crude fibrolytic proteins obtained through desalting in different concentrations of ammonium sulfate: NO.1 and 6 60% CFP, 2 and 7 80% CFP, 3 and 8 100% CFP, 4 80U·mL-1 UK (positive control), 5 0.05M Tris-HCl (negative control).
Figure 2Chromatographic separation maps of CFP. Samples were injected into DEAE-32 cellulose columns connected to the AKTA protein purification system. Each peak represents possible fibrinolytic proteins.
Figure 3SDS-PAGE electrophoresis. Following ion exchange chromatography, the molecular mass of the fibrinolytic proteins were determined via SDS-PAGE (12%).
Protein concentration determination.
| Absorb | Average | Tough Concentration (mg·mL-1) | Salting out gradient | ||
|---|---|---|---|---|---|
| 2.316 | 2.220 | 2.060 | 2.199 | 1.513 | 100% |
| 0.026 | 0.024 | 0.025 | 0.025 | blank | |
Figure 4Protein concentrations and standard curves.
Figure 5Effects of PH on fibrinolytic activity. Five pH conditions were assessed (6.0, 7.0, 8.0, 9.0, and 10.0). Optimal activity was observed at pH 7.0.
Cancer cell proliferation inhibition assays.
| 100% protein | Blank | |||||
|---|---|---|---|---|---|---|
| Protein concentration | 1μg·mL-1 | 25μg·mL-1 | 125μg·mL-1 | 250μg·mL-1 | 500μg·mL-1 | |
| Absorb | 0.87 | 0.78 | 0.749 | 0.761 | 0.154 | 0.788 |
| 0.881 | 0.881 | 0.783 | 0.762 | 0.186 | 0.823 | |
| 0.841 | 0.898 | 0.823 | 0.808 | 0.197 | 0.765 | |
| Average | 0.864 | 0.853 | 0.785 | 0.777 | 0.179 | 0.792 |
| Survival rate(%) | 109.09 | 107.70 | 99.12 | 98.11 | 22.60 | - |
| Inhibition rate(%) | 17.17 | 18.56 | 27.15 | 28.17 | 103.66 | - |